INFUSYSTEM HOLDINGS, INC Unamortized Debt Issuance Expense
INFUSYSTEM HOLDINGS, INC (INFU) had Unamortized Debt Issuance Expense of $333.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2026-08-04
- 2026-06-30: Unamortized Debt Issuance Expense $333.00K.
- 2026-03-31: Unamortized Debt Issuance Expense $354.00K.
- 2025-12-31: Unamortized Debt Issuance Expense $375.00K.
- 2025-09-30: Unamortized Debt Issuance Expense $428.00K.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2026-06-30 | $333.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $354.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $375.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $428.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $233.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $241.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $260.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $280.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $299.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $319.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $338.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $358.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $377.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $208.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $227.00K 10-K · filed 2024-04-10 |
| 2022-09-30 | $245.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $263.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $282.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $300.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $319.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $337.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $355.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $66.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $70.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $75.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $79.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $83.00K 10-K · filed 2021-03-22 |
| 2019-09-30 | $88.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $98.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $107.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $114.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $124.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $105.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $112.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $120.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $127.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $124.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $129.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $109.00K 10-K · filed 2018-03-19 |
| 2016-09-30 | $110.00K 10-Q · filed 2016-12-12 |
| 2016-06-30 | $118.00K 10-Q/A · filed 2016-12-12 |
| 2016-03-31 | $126.00K 10-Q/A · filed 2016-12-12 |
| 2015-12-31 | $134.00K 10-K · filed 2017-03-22 |
| 2012-12-31 | $200.00K 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |